Join Daniel Delubac, CEO of IORGANBIO, for a deep dive into the breakthrough technologies reshaping modern medicine. From non-invasive prenatal testing to the first AI-agentic platforms for synthetic chemistry, Daniel has been at the center of the world's most significant biotech innovations. In this episode, we explore how IORGANBIO is merging first-principles engineering with AI to manufacture human bioequivalent cells and organoids at scale—replacing outdated animal models and paving the way for accessible, $n$-of-one regenerative medicine.

🎯 Insights You’ll Learn:

✓ The Power of NAMs: Why organoids are the key to moving past animal testing in drug discovery

✓ AI-Driven Modeling: Leveraging AI to generate high-fidelity cell and organoid models

✓ Manufacturing Challenges: Solving the bottlenecks in biopharma process dev ...